As the race for the presidency continues, we’ve been hearing a lot about immigrants and immigration reform. Off the campaign trail, in senior living, the topic frequently comes up, too.
Jonesing for separate recognition
By
Lois A. Bowers
Apr 15, 2024
How is it that in my 11 years of writing about the long-term care profession, which has been talking about the coming “silver wave” of baby boomers all that time (and more), I don’t recall ever hearing...
4 lessons from 3 tech wake-up calls
By
Lois A. Bowers
May 15, 2017
Three tech-related stories that made the news Friday serve as wake-up calls for individuals and businesses.
Put fighting ageism on your action plan for 2020
By
Lois A. Bowers
Jan 06, 2020
The top five types of ageist behavior in American occur in the workplace, according to a new survey.
What you need to know about flu vaccination
By
Lois A. Bowers
Oct 07, 2019
Here are some important takeaways about influenza vaccination from my conversation with the medical director of the National Foundation for Infectious Diseases.
A vote for the family caregiver
By
Lois A. Bowers
Nov 07, 2022
A new survey delivers additional food for thought on the business opportunities for senior living providers to serve family caregivers.
Vim and vigor at the ripe old age of 50
By
Lois A. Bowers
May 24, 2021
Maybe Phil Mickelson’s recent accomplishment will remind people that 50-year-olds still have plenty of vim and vigor. In a recent survey, people just a few years older than him provided some insights...
How to succeed at succession planning
By
Lois A. Bowers
Nov 23, 2015
When it comes to succession planning, some senior living organizations have some work to do. Fortunately, they have a few examples to which to look.
Advice for those interested in the middle market
By
Lois A. Bowers
Nov 06, 2023
For senior living and care organizations looking to begin serving the middle market — and judging by the standing-room-only crowd at a session during the LeadingAge Annual Meeting Sunday afternoon, there...
Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).